Compare MPLT & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPLT | NOMD |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2025 | 2015 |
| Metric | MPLT | NOMD |
|---|---|---|
| Price | $6.99 | $12.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $26.54 | $13.77 |
| AVG Volume (30 Days) | 341.4K | ★ 1.2M |
| Earning Date | 12-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 5.55% |
| EPS Growth | ★ 82.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.31 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.77 | $8.99 |
| 52 Week High | $40.43 | $13.08 |
| Indicator | MPLT | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.92 | 61.04 |
| Support Level | N/A | $9.52 |
| Resistance Level | $8.58 | $12.18 |
| Average True Range (ATR) | 0.54 | 0.25 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 11.29 | 75.39 |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.